News About: Pharm. Industry
Kim Myung-sook named Novartis's Sebivo EGM leaderNovartis Korea said Kim Myung-sook, 37, a team leader of Novartis Korea' infection unit, was named a global crew leader (Head Center of Exellence) of Sebivo (telbivudine), a new...
|
Arthritis remedy markets continues to grow next year too.
Functional Food News Paper: "Arthritis market was already verified"
The sales of Glucosamine preparations manufactured locally showed 65 billion won, and the total sales including the imported products (U$30 mil) m...
Humira to be launched in Korea
Abbott Korea said on December 18 that it will launch HUMIRA (adalimumab), a human-derived antibody that binds to human tumor necrosis factor alpha (TNF alpha), from next year, as its efficacy and safety were assessed ...
Drug company put diverse marketing activities for OTC business.
Most of local pharmaceutical companies are now trying to activate their OTC drug business in diverse ways by introducing new products and putting more public advertising campaigns in an attempt to overcome the busines...
KPTA vows to protect domestic pharmaceutical industry
"We will have to resort to a lawsuit to fend off the government's new drug pricing policy that will shake up the domestic pharmaceutical industry, the Korea Pharmaceutical Manufacturers Association (KPMA) said in a st...
Lawsuit planned over new drug pricing policy
The Korea Pharmaceutical Manufacturers Association (KPMA) said on December 14 it is planning to sue the government over the new drug pricing scheme during next month.
The Ministry of Health ad Welfare will introduc...
Green Cross starts building 57 billion won vaccine plant
Green Cross Corporation said on December 14 it started the construction of the nation's new vaccine factory in Hwasun, South Jeolla Province.
The company will invest 44 billion won to complete the facility in 2008,...
Korea's leading 500 insurance drugs pricing under-evaluated by 57 percent
Korea's top 500-drug prices covered by the national health insurance is in the level of 57.1 percent compared with those of seven advanced countries, according to a report released by the Korea Pharmaceutical Manufact...
Kolmar exclusively to distribute AI vaccine in Korea.
Korea Kolmar (CEO: Yoon Dong-han) announced that they made an exclusive distribution agreement for AI vaccine with Vaxin, an American vaccine manufacturer and bio venture company, on Dec. 12 including a stock investme...
Ahmet Goksun to head KRPIAAhmet Goksun, president of Pfizer Korea, was named on December 12 as a new chairman of the Korean Research-based Pharmaceutical Industry Association (KRPIA) and will replace pre...
|
